Shopping Cart
Remove All
Your shopping cart is currently empty
SGF29-IN-1
😃Good
Catalog No. T87383Cas No. 6638-82-0
SGF29-IN-1 (Compound Cpd_DC60) serves as a selective inhibitor targeting the Tudor domain of the Spt-Ada-Gcn5 acetyltransferase (SAGA)-associated factor 29 (SGF29). It has demonstrated effectiveness in treating leukemia [1].
SGF29-IN-1
😃Good
Catalog No. T87383Cas No. 6638-82-0
SGF29-IN-1 (Compound Cpd_DC60) serves as a selective inhibitor targeting the Tudor domain of the Spt-Ada-Gcn5 acetyltransferase (SAGA)-associated factor 29 (SGF29). It has demonstrated effectiveness in treating leukemia [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | SGF29-IN-1 (Compound Cpd_DC60) serves as a selective inhibitor targeting the Tudor domain of the Spt-Ada-Gcn5 acetyltransferase (SAGA)-associated factor 29 (SGF29). It has demonstrated effectiveness in treating leukemia [1]. |
| In vitro | SGF29-IN-1 (20 μM) inhibits the Tudor domain of SGF29, disrupting SGF29-dependent acetylation of H3K9 in leukemia cell lines MOLM13 and MV4-11 [1]. Western Blot Analysis [1] Cell Lines: MOLM13 and MV4-11, Concentration: 20 μM, Incubation Time: 48 hours, Result: Inhibited acetylation of H3K9 and reduced levels of RPL8 and RPS2. |
| In vivo | SGF29-IN-1, administered at 5 mg/kg via intraperitoneal injection every other day for 35 days, effectively inhibits leukemia progression in a mouse model (MLL-AF9 xenograft CD45 mice) with no significant toxicity to CD45 mice [1]. This treatment leads to a reduced percentage of 45.2 cells in the peripheral blood and spleen and improves the survival rate of the rats. |
| Molecular Weight | 519.63 |
| Formula | C33H33N3O3 |
| Cas No. | 6638-82-0 |
| Smiles | C(N1CC=2C3=C(C4=C(C2OC1)CN(CC5=CC=CC=C5)CO4)CN(CC6=CC=CC=C6)CO3)C7=CC=CC=C7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy SGF29-IN-1 | purchase SGF29-IN-1 | SGF29-IN-1 cost | order SGF29-IN-1 | SGF29-IN-1 chemical structure | SGF29-IN-1 in vivo | SGF29-IN-1 in vitro | SGF29-IN-1 formula | SGF29-IN-1 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.